AMT-101 (oral)

DRUG2 trials

Sponsors

Applied Molecular Transport

Conditions

Ulcerative Colitis

Phase 2

Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

Applied Molecular TransportUlcerative Colitis

Start: 2020-08-26End: 2022-12-31Updated: 2022-11-07

Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)

CompletedNCT05372939

Applied Molecular TransportUlcerative Colitis

Start: 2021-02-05End: 2022-07-13Updated: 2022-09-14